Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
25/06/2025 15:34
June 25 (Reuters) - Hamlet BioPharma AB HAMLETb.TE: HAMLET BIOPHARMA HOLDS SUCCESSFUL IN PERSON MEETING WITH US FDA HAMLET BIOPHARMA AB: DISCUSSION PROCEEDED TO COVER FDA'S FEEDBACK ON A NEW PHASE III TRIAL DESIGN FOR NMIBC PATIENTS Source text: ID:nPn5w1hnLa Further company coverage: [HAMLETb.TE] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe